NYC-based Matter Neuroscience secures $26million in funding Polaris Partners led the first round of funding, which was followed by a more recent round that was led by ARCH Venture Partners, Polaris Partners, and Exor Ventures with participation from Collaborative Fund and other investors.
The money will be used by the business to support its ongoing efforts to develop new solutions. Matter Neuroscience was established in 2019 by Axel Bouchon and Ben Goldhirsh, with Chris Shiflett joining as a co-founder in 2021. The company uses neuroscience to offer solutions that assist individuals enhance their happiness and health.
Read also – NYC-based Salvo Health Secures $5Million in Seed Prime Funding
The company has made an early version of its public beta app available to users, and with the support of app usage by the general public, it hopes to advance the technologies it has utilized in clinical tests.
The goal of the software is to give users a way to document and think back on their happy experiences, to comprehend the neurotransmitter activity that underlies them, and to make positive life adjustments. Users of Matter can also access a lecture series on the neuroscience of happiness as well as educational resources.
Read also – PA-based Prolocor Secures $1.7Million in Bridge Funding
About Matter Neuroscience
Matter was formed by Ben Goldhirsh of GOOD Worldwide and the Goldhirsh Foundation, Chris Shiflett of Faculty and Brooklyn Beta, and neurologist Axel Bouchon, who had previously headed the venture arms for Moderna and Bayer.
Their first product is an iOS program that will assist you in documenting life’s greatest occasions, gathering and thinking back on pleasant memories, comprehending the molecular effects of positive encounters, and utilizing your best recollections to create the life you desire.
